On May 9, Russian Health Minister Mikhail Murashko said that many countries were interested in the Covid-19 vaccine Sputnik Light using a dose of Russia.
The new Covid-19 vaccine Sputnik Light was registered on May 6. (Source: Sputnik) According to Russian Health Minister Murashko, just registered a few days ago, the Sputnik Light vaccine has attracted interest abroad. However, Mr. Murashko did not specify which countries have shown interest in this vaccine. Sputnik Light is the first component of Sputnik V – a recombinant human viral vector of serotype 26 (rAd26). The Gamaleya Research Institute, together with the Russian Direct Investment Fund (RDIF), conducted a global trial of the effectiveness of Sputnik Light on February 21, and the vaccine was officially registered on May 6. The data showed that the vaccine was 79.4% effective, higher than many two-component vaccines. The nearly 80% efficacy level is higher than many of the world’s two-dose vaccines, highlighting the vaccine’s proven effectiveness against all new variants. According to a report by the Russian Direct Investment Fund, no serious side effects were noted after vaccination with Sputnik Light; vaccines comply with standard logistics and storage requirements. The single-dose vaccine, which allows more people to be vaccinated in less time, is effective in the fight against the Covid-19 pandemic during the acute phase of development. (according to Sputnik)
You must log in to post a comment.